CGI 2026: A Path Forward for Neglected Disease Research
Jared Bauer reflects on CGI 2026 and Open Impact, Seek Labs’ three-year commitment to advance research on neglected and underserved infectious diseases.
Archive
Blog
All news, publications, and updates from Seek Labs.
-
-
AI Can Design Viruses. Can Our Defenses Adapt Fast Enough?
AI-designed viruses are becoming a reality. Learn how programmable CRISPR could help build faster defenses against emerging and engineered viral threats.
-
From ANINA to SeekIt: What a chemistry breakthrough becomes when it is built into a platform.
From ANINA to SeekIt: What a chemistry breakthrough becomes when it is built into a platform. How Seek Labs is turning a new amplification mechanism into a configurable diagnostic platform for respiratory disease and biosecurity By Jared Bauer, CEO and Co-Founder, Seek Labs | Part 2 of a series on Seek Labs’ ANINA chemistry SeekIt™…
-
ANINA: Molecular Accuracy Without the Laboratory.
Discover how Seek Labs developed ANINA™, a novel isothermal amplification chemistry for molecular accuracy without laboratory infrastructure.
-
The Map Isn’t the Milestone. What It Unlocks Is.
Seek Labs recently announced BioSeeker has mapped CRISPR-addressable regions across all 25 viral families known to infect humans. That is an important infectious disease milestone.
-
Ebola Isn’t One Virus. We’ve Been Treating It Like One.
Ebola Isn’t One Virus. We’ve Been Treating It Like One. By Jared Bauer, CEO Ebola Bundibugyo (BDBV) is the strain driving the current outbreak in the Democratic Republic of the Congo and Uganda — and it is one the world is dangerously unprepared for. “No vaccine exists. No therapy exists. The virus circulated undetected for…
-
For Continuously Evolving Threats like Avian Influenza, We Must Design Durable Anti-Viral Therapeutics
For Continuously Evolving Threats like Avian Influenza, We Must Design Durable Anti-Viral Therapeutics Highly pathogenic avian influenza (HPAI) illustrates a clear and urgent application for Seek Labs’ platform based programmable therapeutic. By Dr. Douglas Gladue | March 11, 2026 Highly pathogenic avian influenza (HPAI) is a persistent and economically disruptive disease threat. It has been…
-
Next Generation CRISPR: How Seek Labs’ Programmable Therapeutics Are Expanding the Promise of CRISPR-Powered Innovation
Next Generation CRISPR: How Seek Labs’ Programmable Therapeutics Are Expanding the Promise of CRISPR-Powered Innovation At Seek Labs, every day is World CRISPR Day. Our work in programmable therapeutics builds upon the same principles that make CRISPR so revolutionary: precision, adaptability, and speed. As we reflect on this transformative technology, we’re not just looking at…
-
We Can’t Feed the World If We Ignore Animal Disease: Why Veterinary Pathogens Are a Global Health Crisis
We Can’t Feed the World If We Ignore Animal Disease: Why Veterinary Pathogens Are a Global Health Crisis According to the WHO, 60% of emerging infectious diseases are zoonotic. And those risks are rising as deforestation and climate shifts push animals closer to humans. By Jared bauer, Ceo of Seek Labs | July 23, 2025…
-
RSV Isn’t Just a Cold — It’s a Global Crisis We Keep Ignoring
RSV Isn’t Just a Cold; It’s a Global Crisis We Keep Ignoring Why RSV is more dangerous than people think and what we’re doing to change that By Jared Bauer, CEO of Seek Labs | july 8, 2025 In January, my wife got sick. Really sick. RSV, influenza, and pneumonia, all at once. She’s a healthy,…
Stay connected
Follow the work as it unfolds.
Stay connected to company milestones, scientific insights, and the work unfolding across BioSeeker, SAT, and Seek Diagnostics.